The independent source for health policy research, polling, and news.
1,781 - 1,800 of 15,467 Results
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
Advocates say two bills under consideration could help migrant communities but that more needs to be done.
While more Medicaid beneficiaries have been purged in the span of a year than ever before, enrollment is on track to settle at pre-pandemic levels.
States are using their Medicaid programs to offer poor and sick people housing services, such as paying six months’ rent or helping hunt for apartments. The trend comes in response to a growing homelessness epidemic, but experts caution this may not be the best use of limited health care money.
Three leading California officials who represented the state at the United Nations climate talks late last year reflect on climate change’s growing threat to human health — and explain what the state is trying to do about it.
Facts don’t support claims by a likely Republican Senate candidate that a federal research laboratory in Montana infected bats with a coronavirus from China before the covid-19 outbreak.
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
A response is ramping up to a potential spillover of the neurological disease to humans from deer, elk, and other animals.
A soon-to-be-finalized legal settlement would offer transgender women in Colorado prisons new housing options, including a pipeline to the Denver Women’s Correctional Facility. The change comes amid a growing number of lawsuits across the country aimed at improving health care access and safety for incarcerated trans people.
As science skepticism pervades politics, the Supreme Court will soon consider two cases that seek to define the power of “experts.” Meanwhile, abortion opponents are laying out plans for how Donald Trump, if reelected as president, could effectively curtail abortion even in states where it remains legal. Sandhya Raman of CQ Roll Call, Joanne Kenen of Johns Hopkins University and Politico Magazine, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Samantha Liss, who reported and wrote the latest KFF Health News-NPR “Bill of the Month” feature about a husband and wife who got billed for preventive care that should have been fully covered.
After the U.S. Supreme Court ended the federal right to an abortion and many states banned the procedure, reproductive health care organizations hired dozens of people to help patients arrange travel and pay for care.
Injectable penicillin is the go-to treatment for syphilis and the only treatment considered safe for pregnant people with the disease. But as rates of syphilis increase across the U.S., a shortage of the injectable has prompted some public health agencies to ration it.
The head of Montana’s health department said the agency is catching up on a months-long backlog of contracts with organizations that connect people to medical care that left organizations without pay, halted some services, and triggered job cuts.
It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.
Ketamine, approved by the FDA as an anesthetic in 1970, is emerging as a major alternative mental health treatment, and there are now more than 500 ketamine clinics around the country. But with little regulation and widely varying treatment protocols, it’s a medical "wild West."
© 2026 KFF